WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'8801 Infant (under 12 months) mortality rate: 412
GDP / capita (US$): 17'5311 Child (under 5 years) mortality rate: 532

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 2'039  2'021  2'004  1'987  1'969  1'755  1'384  998 
Births 48  48  48  48  48  48  48  44 
Surviving infants 46  46  46  46  46  45  45  41 
Pop. less than 5 years 231  232  232  232  230  227  225  188 
Pop. less than 15 years 678  677  677  676  675  673  620  464 
Female 15-49 years 540  535  530  526  522  457  323  229 

Number of reported case

(Click for retrospective incidence data for Botswana)
Diphtheria
Japanese encephalitis
Measles 853  2'672  1'218  4'091 
Mumps
Pertussis 22  110 
Polio*
Rubella 508  121  163  214  13  170 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Botswana)
Vaccine year result method % card seen                                                
BCG 2012  99  EPI   97  93  99*  99*  99*  99*  73 
DTP1 2012  98  EPI   97  99  99*  99*  99*  99*  94 
DTP3 2012  95  EPI   97  94  79  99*  99*  95  85 
DTP4         
IPV1         
HepB_BD          91  99*  99*  99*  99*  86 
HepB3 2012  95  EPI   97  94  99*  99*  82  73 
Hib3 2012  95  EPI   97  94  99*  99* 
JapEnc         
MCV1          93  93  99*  99*  94  84 
MCV2          85  82 
PCV1          99  99*  99* 
PCV3          81  65  52 
Pol3 2012  97  EPI   97  86  86  98  99*  99*  85 
Rota1          98  96  99* 
Rota_last          82  78  74 
Rubella1         
TT2plus 2012  55  EPI   97  52  70  79  81  64  45 
PAB         
VAD1          97  79  90  99* 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Botswana)
BCG 98  98  98  98  98  99  93  92 
DTP1 98  98  98  98  98  98  99  89 
DTP3 95  95  95  95  95  97  92  71 
HepB3 95  95  95  95  95  86 
HepB_BD 99  99  99  99  99  99 
Hib3 96  96  96  95 
MCV1 97  97  97  97  96  91  87  63 
MCV2 85  83 
PAB 92  92  92  92  92  80  59 
PCV3 81  65  52 
Pol3 96  96  96  96  96  97  90  46 
Rota_last 82  78  74 

Number of districts in the country 24  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 75
From 80 to 89% 4
From 50 to 79% 21
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 18 months; 7 years;
DTwPHibHepB 2, 3, 4 months; Yes
HPV 1st contact, +6 months; No girls aged 9-13 years in St 5, 6 and 7 and out of school
HepB birth; Yes
IPV Yes From June 2015
Measles 9, 18 months; Yes
OPV 2, 3, 4, 18 months; 7 years; Yes
Pneumo_conj 2, 3, 4 months; Yes
Rotavirus 2, 3 months; Yes
TT 1st contact pregnancy; +4 weeks; +6 months; +1, +1 year; Yes
VitaminA 6-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 24  24  24  24 

System performance

Total Nº districts in country number 24  24  24  24  24  24  24 
Nº districts with DTP3 coverage >=80% number 19  14  18  17  22  23  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 79  58  75  71  92  96  96 
Nº districts with measles (MCV1) coverage >=95% number 14  12  16  16  14  11  13 
% of districts with MCV1 coverage >=95% From 0 to 100% 58  50  67  67  58  46  54 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No    No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes        No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 97  100    98  92  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.